valsartan has been researched along with Arteriosclerosis Obliterans in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Feng, N; Wang, F; Wang, L; Yao, W | 1 |
1 trial(s) available for valsartan and Arteriosclerosis Obliterans
Article | Year |
---|---|
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis Obliterans; C-Reactive Protein; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Interleukin-6; Male; Middle Aged; Peripheral Arterial Disease; Single-Blind Method; Stents; Valsartan | 2020 |